DENVER, Oct. 8 /PRNewswire-FirstCall/ -- Vyta Corp (OTC Bulletin Board: VYTC) today announced that effective October 7, 2008, Dr. Nino Sorgente has been formally engaged as an independent scientific consultant to Vyta Corp. Dr. Sorgente was formerly Vice President of Research and Development at BIOAGRA, LLC, a joint venture, equally owned by Vyta Corp and Justin Holdings, Inc. On September 15, 2008, Vyta Corp announced its filing of foreclosure litigation against BIOAGRA, LLC. BIOAGRA, LLC manufactures, markets and distributes AGRASTIM(R), a proprietary all-natural, biologically active yeast Beta-1,3/1,6-D-glucan feed supplement.
"We are pleased to retain the services of Dr. Sorgente," said Paul H. Metzinger, President and CEO of Vyta Corp. "Dr. Sorgente is recognized as one of the leading Beta glucan researchers for his contributions to the cosmetic, medical and agricultural applications of Beta glucan."
About Vyta Corp
Vyta Corp, based in Denver, Colorado, is traded on the over-the-counter NASDAQ stock market (OTCBB: VYTC) as well as on the Frankfurt, Hamburg, XETRA and Munich Exchanges (OTC:VYTA).
In addition to its interest in BIOAGRA, LLC, Vyta Corp owns various patents and intellectual properties related to NCS(R) (NanoPierce Connection System) an advanced electronic connection system. For more information on Vyta Corp, please visit its website at http://www.vytacorp.com .
About BIOAGRA, LLC
BIOAGRA, LLC is based in Hinesville, Georgia, where it produces, markets and sells AGRASTIM(R), which is a purified, all natural, nontoxic yeast Beta 1,3/1,6-D-glucan product with a high bioactivity function that improves the immune systems of animals and humans. AGRASTIM(R) is also used to replace growth promotion antibiotics that are currently used in the feed of the beef and dairy cattle, equine, swine, poultry and aquaculture industries.
This announcement contain
|SOURCE Vyta Corp|
Copyright©2008 PR Newswire.
All rights reserved